Selected Publications
Wethington SL, Shah PD, Martin L, Tanyi JL, Latif N, Morgan M, Torigian DA, Rodriguez D, Smith SA, Dean E, Domchek SM, Drapkin R, Shih IM, Brown EJ, Hwang WT, Armstrong DK, Gaillard S, Giuntoli R, Simpkins F: Combination ATR (ceralasertib) and PARP (olaparib) Inhibitor (CAPRI) trial in acquired PARP-inhibitor-resistant homologous recombination deficient ovarian cancer. Clin Cancer Res 29(15):2800-2807 : 2023.
Nasioudis D, Gysler S, Latif N, Ko E, Cory L, Giuntoli II RL, Kim S, Simpkins F: Molecular profiling of mucinous ovarian carcinoma reveals actionable mutations and a unique genomic profile. (Poster) 54th Society of Gynecologic Oncology annual meeting, Tampa, FL : 2023.
Nasioudis D, Gysler S, Latif NA, Ko EM, Cory L, Kim SH, Giuntoli II RL: Non-operative management of clinical early-stage endometrioid endometrial carcinoma: hormonal or radiation therapy? (Poster) 54th Society of Gynecologic Oncology annual meeting, Tampa, FL : 2023.
Nasioudis D, Gysler S, Ko E, Cory L, Giuntoli II R, Kim S, Latif N: Next generation sequencing reveals distinct molecular subgroups of endometrioid ovarian carcinoma. (Poster) 54th Society of Gynecologic Oncology annual meeting, Tampa, FL : 2023.
Nasioudis D, Gysler S, Latif NA, Ko EM, Cory L, Kim SH, Cliby WA, Giuntoli II RL: High rates of neo-adjuvant chemotherapy use in high-risk advanced stage epithelial ovarian carcinoma is associated with improved outcomes. (Poster) 54th Society of Gynecologic Oncology annual meeting, Tampa, FL : 2023.
Nasioudis D, Gysler S, Latif N, Ko E, Cory L, Giuntoli R, Kim S, Simpkins F: Prevalence of ESR1 gene mutations in gynecologic malignancies with high-estrogen receptor expression. (Poster) 54th Society of Gynecologic Oncology annual meeting, Tampa, FL : 2023.
Abu-Rustum N, Yashar C, Arend R, Barber E, Bradley K, Brooks R, Campos SM, Chino J, Chon HS, Chu C, Crispens MA, Damast S, Fisher CM, Frederick P, Gaffney DK, Giuntoli R, Han E, Holmes J, Howitt BE, Lea J, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Podoll M, Salani R, Schorge J, Siedel J, Sisodia R, Soliman P, Ueda S, Urban R, Wethington SL, Wyse E, Zanotti K, McMillian NR, Aggarwal SJ: Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology. Natl Compr Canc Netw 21(2):181-209 : 2023.
Nasioudis D, Latif NA, Ko EM, Cory L, Kim SH, Simpkins F, Morgan MA, Giuntoli RL 2nd: Facility level variation in the utilization of neoadjuvant chemotherapy is associated with higher surgical morbidity for patients with advanced stage epithelial ovarian carcinoma. Gynecol Oncol 169:41-46 : 2023.
Nasioudis D, Latif NA, Haggerty AF, Cory L, Giuntoli II RL, Kim SH, Morgan MA, Simpkins F, Ko EM: Molecular landscape of EBBR2/HER2 gene amplification among patients with endometrial carcinoma Featured Poster International Gynecologic Cancer Society Meeting, New York : 2022.
Nasioudis D, Taunk NK, Ko EM, Haggerty AF, Cory L, Giuntoli RL 2nd, Kim SH, Latif NA: Addition of External Beam Radiation Therapy to Adjuvant Chemotherapy for Patients With Stage IIIC Uterine Endometrioid Carcinoma: Utilization and Outcomes. Am J Clin Oncol 45(9):373-378 : 2022.
Academic Contact Information
Jordan Center for Gynecologic Oncology at Penn Perelman Center for Advanced Medicine
3400 Civic Center Blvd.
10th Floor South
Philadelphia,
PA
19104
Phone: 800-789-7366
Patient appointments: 800-789-7366